Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Oncogene Ras affects memory consolidation

Jan. 20, 2020

New compounds for Huntington's disease presented by PTC Therapeutics

Jan. 20, 2020

AlzeCure Pharma presents Trk-A and/or Trk-B and/or Trk-C modulators

Jan. 20, 2020

Clene opens phase II study of CNM-Au8 in ALS

Jan. 17, 2020

Roche, ETHZ disclose new cannabinoid CB2 receptor ligands

Jan. 17, 2020

Norepinephrine is "unexpected connection" between amyloid and tau

Jan. 17, 2020

Rett gene affects maternal behavior via cortical plasticity

Jan. 17, 2020

Pancreatitis protein promotes pain

Jan. 17, 2020

GeneTx Biotherapeutics cleared to begin phase I/II study of GTX-102 in Angelman syndrome

Jan. 16, 2020

Neurodegeneration treatment candidate IW-6463 well tolerated in phase I study

Jan. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...